Incyte to Present at Upcoming Investor Conference

Rhea-AI Summary

Incyte will present at the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022, at 11:20 a.m. ET. The event will be held virtually, and the presentation will be accessible via a live webcast on Investor.Incyte.com, with a replay available for 30 days. Incyte, based in Wilmington, Delaware, focuses on developing proprietary therapeutics to address serious medical needs. For more information, visit Incyte.com.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it will present at the 11^th Annual SVB Leerink Global Healthcare Conference (Virtual) on Thursday, February 17, 2022 at 11:20 a.m. ET.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220203005010/en/

Incyte

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com

Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

When is Incyte presenting at the SVB Leerink Global Healthcare Conference?

Incyte will present on February 17, 2022, at 11:20 a.m. ET.

How can I watch the Incyte presentation at the conference?

The presentation will be available via a live webcast on Investor.Incyte.com.

Will the Incyte presentation be available after the live event?

Yes, the presentation will be available for replay for 30 days.

What does Incyte focus on in its business operations?

Incyte focuses on discovering and developing proprietary therapeutics for serious unmet medical needs.